Mitigation of Trypanosoma congolense-Associated Anemia and Expression of Trans-sialidase (TconTS) Gene Variants by Eugenol.
Anemia
Eugenol
Gene expression
Renal hypertrophy
T. congolense
Trans-sialidases
Journal
Acta parasitologica
ISSN: 1896-1851
Titre abrégé: Acta Parasitol
Pays: Switzerland
ID NLM: 9301947
Informations de publication
Date de publication:
26 Dec 2023
26 Dec 2023
Historique:
received:
03
11
2022
accepted:
13
11
2023
medline:
26
12
2023
pubmed:
26
12
2023
entrez:
26
12
2023
Statut:
aheadofprint
Résumé
African Animal Trypanosomosis (AAT) caused by Trypanosoma congolense is a parasitic disease affecting the livestock industry in sub-Saharan Africa and usually results in severe anemia, organ damage, and ultimately the death of the infected host. The present study was designed to investigate the possible chemotherapeutic effect of eugenol on T. congolense infections and its inhibitory effect on the trans-sialidase (TconTS) gene expression. Animals were infected with T. congolense and treated with 15 and 30 mg/kg body weight (BW) of eugenol for ten (10) days. The eugenol (15 mg/kg BW) significantly (P < 0.05) reduced the T. congolense proliferation, increased animal survival, and reduced serum urea level. However, both dosages of eugenol significantly (P < 0.05) ameliorated T. congolense-induced anemia, renal hypertrophy, splenomegaly, and reduced total damage score in the liver and kidney of infected animals. In addition, the compound significantly (P < 0.05) downregulated the expression levels of TconTS1, TconTS2, TconTS3, and TconTS4 but the effect was more pronounced (sevenfold reduction) on TconTS1. The oral administration of eugenol suppressed T. congolense proliferation and prevented some major pathologies associated with trypanosomiasis infection. The reversal of renal hypertrophy and splenomegaly by the compound in addition to the reduction in the expression level of the TconTS gene variants could explain the observed anemia ameliorative potential of the compound.
Identifiants
pubmed: 38147296
doi: 10.1007/s11686-023-00750-6
pii: 10.1007/s11686-023-00750-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Koliwer-Brandl H, Gbem TT, Waespy M, Reichert O, Mandel P, Drebitz E, Dietz F, Kelm S (2011) Biochemical characterization of trans-sialidase TS1 variants from Trypanosoma congolense. BMC Biochem 12:39. https://doi.org/10.1186/1471-2091-12-39
doi: 10.1186/1471-2091-12-39
pubmed: 21801439
pmcid: 3173295
Cayla M, Rojas F, Silvester E, Venter F, Matthews KR (2019) African trypanosomes. Parasites & vectors 12(1):190. https://doi.org/10.1186/s13071-019-3355-5
doi: 10.1186/s13071-019-3355-5
Steverding D (2008) The history of African trypanosomiasis. Parasit Vectors 1(1):3. https://doi.org/10.1186/1756-3305-1-3
doi: 10.1186/1756-3305-1-3
pubmed: 18275594
pmcid: 2270819
Ibrahim MA, Isah MB, Abdullahi AS (2016) Antioxidant therapy against trypanosome infections. Curr Top Med Chem 16:2233–2244. https://doi.org/10.2174/1568026616666160413125622
doi: 10.2174/1568026616666160413125622
pubmed: 27072713
Umar IA, Maryoms NG, Daikwo E, Gidado A, Buratai LB, Igbokwe IO, Ibrahim MA (2009) The effects of consumption of Hibiscus sabdariffa calyces on hematological profile and organ pathological changes in Trypanosoma congolense infected rats. Afr J Tradit Complement Altern Med 6:585–591
pubmed: 20606781
pmcid: 2816476
Aminu R, Ibrahim MA, Rahman MA, Dash R, Umar IA (2017) Trypano-suppressive effects of ellagic acid and amelioration of the trypanosome-associated pathological features coupled with inhibitory effects on trypanosomal sialidase in vitro and in silico. Phytomedicine 30:67–73. https://doi.org/10.1016/j.phymed.2017.04.013
doi: 10.1016/j.phymed.2017.04.013
pubmed: 28545671
Penas FN, Cevey AC, Siffo S, Mirkin GA, Goren NB (2016) Hepatic injury associated with Trypanosoma cruzi infection is attenuated by treatment with 15- deoxy-Δ12, 14 prostaglandin J2. Exp Parasitol 170:100–108. https://doi.org/10.1016/j.exppara.2016.09.015
doi: 10.1016/j.exppara.2016.09.015
pubmed: 27693222
Saad SB, Ibrahim MA, Jatau ID, Shuaibu MN (2019) Trypanostatic activity of geranylacetone: Mitigation of Trypanosoma congolense-associated pathological perturbations and insight into the mechanism of anemia amelioration using in vitro and in silico models. Exp Parasitol 201:49–56. https://doi.org/10.1016/j.exppara.2019.04.011
doi: 10.1016/j.exppara.2019.04.011
pubmed: 31029700
Gbem TT, Waespy M, Hesse B, Dietz F, Smith J, Chechet GD, Nok AJ, Kelm S (2013) Biochemical diversity in the Trypanosoma congolense trans-sialidase family. PLOS Negl Trop Dis 7(12):e2549. https://doi.org/10.1371/journal.pntd.0002549
doi: 10.1371/journal.pntd.0002549
pubmed: 24340108
pmcid: 3855035
Balogun EO, Balogun JB, Yusuf S, Inuwa HM, Ndams IS, Sheridan P, Inaoka DK, Shiba T, Harada S, Kita K, Esievo KAN, Nok AJ (2014) Anemia amelioration by lactose infusion during trypanosomosis could be associated with erythrocytes membrane de-galactosylation. Vet Parasitol 199:259–263. https://doi.org/10.1016/j.vetpar.2013.10.013
doi: 10.1016/j.vetpar.2013.10.013
pubmed: 24238624
Coustou V, Plazolles N, Guegan F, Baltz T (2012) Sialidases play a key role ininfection and anaemia in Trypanosoma congolense animal trypanosomiasis. Cell Microbiol 14:431–445. https://doi.org/10.1111/j.1462-5822.2011.01730.x
doi: 10.1111/j.1462-5822.2011.01730.x
pubmed: 22136727
Habila N, Mairo HM, Idowu AA, Michael UU, Emmanuel H (2012) Pathogenic mechanisms of Trypanosoma evansi infections. Res Vet Sci 93:13–17. https://doi.org/10.1016/j.rvsc.2011.08.011
doi: 10.1016/j.rvsc.2011.08.011
pubmed: 21940025
Sallau AB, Ibrahim MA, Salihu A, Yusuf IA (2008) Bloodstream form of Trypanosoma evansi contains b-galactosidase. Middle East J Sci Res 3:49–52
Guegan F, Plazolles N, Baltz T, Coustou V (2013) Erythrophagocytosis of desialylated red blood cells are responsible for anaemia during Trypanosoma vivax infection. Cell Microbiol 15:1285–1303. https://doi.org/10.1111/cmi.12123
doi: 10.1111/cmi.12123
pubmed: 23421946
Amaya MF, Watts AG, Damager I, Wehenkel A, Nguyen T, Buschiazzo A, Paris G, Frasch AC, Withers SG, Alzari PM (2004) Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Structure 12:775–784. https://doi.org/10.1016/j.str.2004.02.036
doi: 10.1016/j.str.2004.02.036
pubmed: 15130470
Onyilagha C, Uzonna JE (2019) Host immune responses and immune evasion strategies in African trypanosomiasis. Front Immunol 10:2738. https://doi.org/10.3389/fimmu.2019.02738
doi: 10.3389/fimmu.2019.02738
pubmed: 31824512
pmcid: 6883386
Assefa S, Shibeshi W (2018) Drug resistance in African animal trypanosomes: a review. Afr J Microbiol Res 12(17):380–386
doi: 10.5897/AJMR2017.8754
Aminu R, Umar IA, Rahman MA, Ibrahim MA (2017) Stigmasterol retards the proliferation and pathological features of Trypanosoma congolense infection in rats and inhibits trypanosomal sialidase in vitro and in silico. Biomed Pharmacother 89:482–489. https://doi.org/10.1016/j.biopha.2017.02.068
doi: 10.1016/j.biopha.2017.02.068
pubmed: 28249250
Saad SB, Ibrahim MA, Jatau ID, Shuaibu MN (2020) The therapeutic potential of phytol towards Trypanosoma congolense infection and the inhibitory effects against trypanosomal sialidase. Exp Parasitol 216:107943. https://doi.org/10.1016/j.exppara.2020.107943
doi: 10.1016/j.exppara.2020.107943
pubmed: 32598890
Abdulrashid NI, Aminu S, Adamu RM, Tajuddeen N, Isah MB, Jatau ID, Aliyu AB, Simelane MBC, Onyike E, Ibrahim MA (2022) Phloroglucinol as a potential candidate against Trypanosoma congolense infection: Insights from in vivo, in vitro, molecular docking and molecular dynamic simulation analyses. Molecules 27(2):469. https://doi.org/10.3390/molecules27020469
doi: 10.3390/molecules27020469
pubmed: 35056785
pmcid: 8781988
Aminu S, Ibrahim MA, Dada Chechet G, Onyike E (2022) Chemotherapeutic potentials of β-ionone against Trypanosoma congolense infection: Inhibition of parasite proliferation, anemia development, trans-sialidase (TconTS3 and TconTS4) gene expressions, and phospholipase A
doi: 10.1111/cbdd.14048
pubmed: 35353953
Marchese A, Barbieri R, Coppo E, Orhan IE, Daglia M, Nabavi SF, Izadi M, Abdollah M, Nabavi SM, Ajami M (2017) Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint. Crit Rev Microbiol 43(6):668–689. https://doi.org/10.1080/1040841X.2017.1295225
doi: 10.1080/1040841X.2017.1295225
pubmed: 28346030
Mamilla R, Raja C, Srinivasan V, Selvaraj S, Mahapatra SK (2015) Eugenol: a versatile phytomedicine. Pharm Anal Acta 6:5. https://doi.org/10.4172/2153-2435.1000367
doi: 10.4172/2153-2435.1000367
Teles AM, Silva-Silva JV, Fernandes JMP, Abreu-Silva AL, Calabrese KS, Adenilde NEM, Mouchrek N, Almeida-Souza F (2021) GC-MS Characterization of antibacterial, antioxidant, and antitrypanosomal Activity of Syzygium aromaticum essential oil and eugenol. Evid Based Complement Alternat Med 2021:1–12. https://doi.org/10.1155/2021/6663255
doi: 10.1155/2021/6663255
Adams ER, Malele II, Msangi AR, Gibson WC (2006) Trypanosome identification in wild tsetse populations in Tanzania using generic primers to amplify the ribosomal RNA ITS-1 region. Acta Trop 100:103–109. https://doi.org/10.1016/j.actatropica.2006.10.002
doi: 10.1016/j.actatropica.2006.10.002
pubmed: 17109808
Mugnier MR, Cross GAM, Papavasiliou FN (2015) The in vivo dynamics of antigenic variation in Trypanosoma brucei. Science 347(6229):1470–1473. https://doi.org/10.1126/science.aaa4502
doi: 10.1126/science.aaa4502
pubmed: 25814582
pmcid: 4514441
Pei RS, Zhou F, Ji BP, Xu J (2009) Evaluation of combined antibacterial effects of eugenol, cinnamaldehyde, thymol, and carvacrol against E. coli with an improved method. J Sci Food Agric 74(7):M379–M383. https://doi.org/10.1111/j.1750-3841.2009.01287.x
doi: 10.1111/j.1750-3841.2009.01287.x
Hammond BR Jr, Renzi LM (2013) Carotenoids. Adv Nutr. 4(4):474–476. https://doi.org/10.3945/an.113.004028
doi: 10.3945/an.113.004028
pubmed: 23858095
pmcid: 3941826
Nejad SM, ÖzgüneşH BN (2017) Pharmacological and toxicological properties of eugenol. Turkish J Pharm Sci 14(12):201–206. https://doi.org/10.4274/tjps.62207
doi: 10.4274/tjps.62207
Stijlemans B, De Baetselier P, Magez S, Van Ginderachter JA, De Trez C (2018) African trypanosomiasis-associated anaemia: the contribution of the interplaybetween parasites and the mononuclear phagocyte system. Front Immunol 9:218. https://doi.org/10.3389/fimmu.2018.00218
doi: 10.3389/fimmu.2018.00218
pubmed: 29497418
pmcid: 5818406
Wang GL, Semenza GL (1996) Molecular basis of hypoxia-induced erythropoietin expression. Curr Opin Hematol 3:156–162. https://doi.org/10.1097/00062752-199603020-00009
doi: 10.1097/00062752-199603020-00009
pubmed: 9372067
Stijlemans B, Brys L, Korf H, Bieniasz-Krzywiec P, Sparkes A, Vansintjan L, Leng L, Vanbekbergen N et al (2016) MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis. PLoS Pathog 12:e1005862. https://doi.org/10.1371/journal.ppat.1005862
doi: 10.1371/journal.ppat.1005862
pubmed: 27632207
pmcid: 5025191
Heideveld E, van den Akker E (2017) Digesting the role of bone marrow macrophages on hematopoiesis. Immunobiology 2017(222):814–822. https://doi.org/10.1016/j.imbio.2016.11.007
doi: 10.1016/j.imbio.2016.11.007
Liu G, Sun D, Wu H, Zhang M, Huan H, Xu J, Zhang X, Zhou H, Shi M (2015) Distinct contributions of CD4+and CD8+T cells to pathogenesis of trypanosoma brucei infection in the context of gamma interferon and interleukin-10. Infect Immun 83(7):2785–2795. https://doi.org/10.1128/iai.00357-15
doi: 10.1128/iai.00357-15
pubmed: 25916989
pmcid: 4468542
Ito M, Murakami K, Yoshino M (2005) Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food Chem Toxicol 43:461–466. https://doi.org/10.1016/j.fct.2004.11.019
doi: 10.1016/j.fct.2004.11.019
pubmed: 15680683